AVANDIA Drug Profile, 2020

$600.00

AVANDIA Drug Profile, 2020

This report focuses on AVANDIA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 021071 Category:

Description

AVANDIA Drug Profile, 2020

This report focuses on AVANDIA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for AVANDIA
  • US Patents
  • Expired US Patents
  • US District Court Litigation
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Finished Product Suppliers
  • Bulk API Sources